Lasmiditan: an additional therapeutic option for the acute treatment of migraine

Taylor and Francis Group, Expert Review of Neurotherapeutics, 5(21), p. 491-502, 2021

Journal article published in 2021 by Daniele Martinelli

, Cristina Tassorelli

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by